Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment

J. J. van der Harst*, G. J. Luijckx

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    7 Citations (Scopus)

    Abstract

    Tuberculosis (TB) with central nervous system (CNS) manifestation is a form of TB with a high mortality and morbidity. Tuberculous meningitis (TM) is the most common form of CNS-TB. Although diagnosis of CNS-TB can be challenging, early treatment of CNS-TB is related to a better outcome. If CNS-TB is suspected, even though the clinical picture is not specific, it should be immediately treated.

    For the treatment of CNS-TB, knowledge of the penetration across the blood-brain barrier of the various antituberculosis agents used in TB treatment is important. These will be described here in order to serve as a guide in choosing a treatment for CNS-TB. Corticosteroids have an evidence-based value in the treatment of TM and so are recommended. As for thalidomide use in CNS-TB, sound evidence is still lacking. We will also include a description of the adverse neurotoxic effects of the various other agents including their psychiatric, ototoxic and ophthalmic adverse effects.

    Original languageEnglish
    Pages (from-to)2940-2947
    Number of pages8
    JournalCurrent Pharmaceutical Design
    Volume17
    Issue number27
    DOIs
    Publication statusPublished - Sept-2011

    Keywords

    • Tuberculosis
    • central nervous system
    • tuberculous meningitis
    • antituberculosis agents
    • blood-brain barrier
    • corticosteroids
    • thalidomide
    • adverse neurotoxic effects
    • EARLY BACTERICIDAL ACTIVITY
    • CEREBROSPINAL-FLUID
    • PULMONARY TUBERCULOSIS
    • RESISTANT TUBERCULOSIS
    • RETROSPECTIVE ANALYSIS
    • MULTIDRUG-RESISTANT
    • MYASTHENIC SYNDROME
    • OCULAR TOXICITY
    • OPTIC NEURITIS
    • SHUNT SURGERY

    Fingerprint

    Dive into the research topics of 'Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment'. Together they form a unique fingerprint.

    Cite this